G. Kevin Lokay's most recent trade in Galera Therapeutics Inc was a trade of 48,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 24, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Galera Therapeutics Inc | G. Kevin Lokay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 48,000 | 48,000 | - | - | Stock Option (Right to Buy) | |
| Galera Therapeutics Inc | Kevin G. Lokay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 48,000 | 48,000 | - | - | Stock Option (Right to Buy) | |
| Galera Therapeutics Inc | Kevin G. Lokay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Galera Therapeutics Inc | Kevin G. Lokay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 9,888 | 9,888 | - | - | Stock Option (Right to Buy) |